Real-world healthcare costs for patients treated with chimeric antigen receptor T-cell therapy in Canada. Masucci L, Kuruvilla J, Sander B, Prica A, et al. Leuk Lymphoma 2025;66:1875-1883.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Masucci L, Kuruvilla J, Sander B, Prica A, et al. Real-world healthcare costs for patients treated with chimeric antigen receptor T-cell therapy in Canada. Leuk Lymphoma 2025;66:1875-1883.
PMID: 40525245